Furthermore, type I IFNs cause mitochondrial malfunction and inflammation in dermatomyositis patients.8 Additionally they enhance the production of B-cell activating factor (BAFF) which contributes to autoantibody production through differentiation of B-cells to plasma cells.20 This evidence concerns the gene TNFSF13B and dermatomyositis.